Angiodynamic Inc [ANGO] stock is trading at $6.40, up 4.23%. An important factor to consider is whether the stock is rising or falling in short-term value. The ANGO shares have gain 4.92% over the last week, with a monthly amount drifted -14.78%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Angiodynamic Inc [NASDAQ: ANGO] stock has seen the most recent analyst activity on April 05, 2024, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $12 for it. Previously, H.C. Wainwright started tracking the stock with Buy rating on September 25, 2023, and set its price target to $19. On April 17, 2023, downgrade downgraded it’s rating to Outperform and revised its price target to $13 on the stock. Canaccord Genuity upgraded its rating to a Buy and increased its price target to $37 on October 15, 2021. Oppenheimer initiated its recommendation with a Perform. Raymond James upgraded its rating to Strong Buy for this stock on November 25, 2020, but kept the price target unchanged to $18. In a note dated April 08, 2020, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
Angiodynamic Inc [ANGO] stock has fluctuated between $5.26 and $8.25 over the past year. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. Angiodynamic Inc [NASDAQ: ANGO] shares were valued at $6.40 at the most recent close of the market. An investor can expect a potential return of 134.37% based on the average ANGO price forecast.
Analyzing the ANGO fundamentals
Angiodynamic Inc [NASDAQ:ANGO] reported sales of 292.73M for the trailing twelve months, which represents a drop of -14.22%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.82%, and Net Profit Margin reading is -0.83%. To continue investigating profitability, this company’s Return on Assets is posted at -0.83, Equity is -0.95 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.21 points at the first support level, and at 6.02 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.53, and for the 2nd resistance point, it is at 6.66.
Ratios To Look Out For
For context, Angiodynamic Inc’s Current Ratio is 2.25. On the other hand, the Quick Ratio is 1.41, and the Cash Ratio is 0.72. Considering the valuation of this stock, the price to sales ratio is 0.89, the price to book ratio is 1.33.
Transactions by insiders
Recent insider trading involved Nighan Warren JR, SVP Quality and Regulatory, that happened on Oct 07 ’24 when 768.0 shares were purchased. SVP Quality and Regulatory, Nighan Warren JR completed a deal on Oct 10 ’24 to buy 100.0 shares. Meanwhile, EVP and CFO Trowbridge Stephen A bought 1700.0 shares on Oct 08 ’24.
